Registration of published randomized trials: a systematic review and meta-analysis

Zarin DA(2008)Medicine. Moving toward transparency of clinical trials Science 319 1340-1342

Tse T(2004)Clinical trial registration: a statement from the International Committee of Medical Journal Editors N Engl J Med 351 1250-1251

De Angelis C(2014)Increasing value and reducing waste: addressing inaccessible research Lancet 383 257-266

Drazen JM(2004)Failing the public health--rofecoxib, Merck, and the FDA N Engl J Med 351 1707-1709

Frizelle FA(2004)Risk of cardiovascular events and rofecoxib: cumulative meta-analysis Lancet 364 2021-2029

Haug C(2009)Outcome reporting in industry-sponsored trials of gabapentin for off-label use N Engl J Med 361 1963-1971

Hoey J(2012)Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin litigation Trials 13 136-958

Horton R(2005)Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1) BMJ 330 956-166

Kotzin S(2010)Outcome reporting among drug trials registered in ClinicalTrials.gov Ann Intern Med 153 158-2004

Laine C(2017)Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications JAMA 318 1709-1354

Zarin DA(2008)Medicine. Moving toward transparency of clinical trials Science 319 1340-1342

Tse T(2004)Clinical trial registration: a statement from the International Committee of Medical Journal Editors N Engl J Med 351 1250-1251

De Angelis C(2014)Increasing value and reducing waste: addressing inaccessible research Lancet 383 257-266

Drazen JM(2004)Failing the public health--rofecoxib, Merck, and the FDA N Engl J Med 351 1707-1709

Frizelle FA(2004)Risk of cardiovascular events and rofecoxib: cumulative meta-analysis Lancet 364 2021-2029

Haug C(2009)Outcome reporting in industry-sponsored trials of gabapentin for off-label use N Engl J Med 361 1963-1971

Hoey J(2012)Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin litigation Trials 13 136-958

Horton R(2005)Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1) BMJ 330 956-166

Kotzin S(2010)Outcome reporting among drug trials registered in ClinicalTrials.gov Ann Intern Med 153 158-2004

Laine C(2017)Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications JAMA 318 1709-1354